• The Thomas C Chalmers Award is awarded at each Cochrane Colloquium for the principal author of the best oral or poster presentation addressing methodological issues related to systematic reviews. In 2005, the panel agreed that the Award should in future be given for both the best oral and the best poster presentation.
• The Kenneth Warren Prize is awarded at each Cochrane Colloquium to the principal author of whichever Cochrane systematic review authored by a national living in a developing country is judged to be both of high methodological quality and relevant to health problems in developing countries.
• The Chris Silagy Prize is awarded at each Cochrane Colloquium to an individual (or team) who has made "an extraordinary contribution to the work of The Cochrane Collaboration".
• The Bill Silverman Prize is awarded at each Cochrane Colloquium to acknowledge explicitly the value of criticism of The Cochrane Collaboration, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about health care by providing the best possible evidence on the effects of healthcare interventions.
The Thomas C Chalmers Award
Thomas C Chalmers, MD
Throughout his career, Tom was an outspoken advocate of randomised
trials, whether at the bedside, at professional meetings, in class,
or in situations pertaining to his own life. After his diagnosis
of prostate cancer in 1993, he insisted that he only receive treatment
in the context of a clinical trial. Fortunately, 
there
was an ongoing trial at Dartmouth Hitchcock Medical Center in which
he enrolled. Over the course of his illness, he delighted in quizzing
and lecturing the residents and physicians caring for him about
the evidence for their tests and interventions. He loved to teach,
frequently using argument as a device. His creativity spanned his
entire career, influencing clinicians and methodologists alike.
He is perhaps best known for the notion 'randomise the first
patient', his belief that it is more ethical to randomise patients
than to treat them in the absence of good evidence.
In his later years, in arguably his most important work, Tom and
his colleagues showed that, had information from RCTs been systematically
and cumulatively synthesised, important treatments such as thrombolytic
therapy for myocardial infarction would have been recognised as
useful earlier. In addition, he demonstrated that the advice given
in textbooks and review articles published over the same period
of time did not correspond to the available evidence, even fifteen years
after an intervention's effect had been well characterised.
The Thomas C Chalmers Award
The Thomas C Chalmers Award was established with individual
donations to celebrate and recognise Tom’s interests, and
was awarded for the first time at the 2nd Cochrane Colloquium in
Hamilton, Ontario, Canada, in October 1994. The Award is given at
each Cochrane Colloquium to the principal authors of the best oral and the best poster presentation
addressing methodological issues related to systematic reviews.
The presentations must demonstrate originality of thought, high quality
science, relevance to the advancement of the science of systematic
reviews, and clarity of presentation [click
here for details of the selection criteria and process and membership
of selection panel]. The recipients receive a certificate and 1000 US dollars (to be split equally between the two recipients). Any
runners-up also receive certificates.
Thomas C Chalmers Award recipients
1994 1995 1996 1997 1998 1999 2000 2001
2002 2003 2004 2005 2006 2007 2008
1994 - Counsell CE, Clarke MJ,
Slattery J, Sandercock PAG. The miracle of DICE therapy for acute
stroke: fact or fictional product of subgroup analysis [abstract]. Proceedings of the Second Cochrane Colloquium,
1994.
Full publication: Counsell CE, Clarke MJ, Slattery J, Sandercock PAG. The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? BMJ 1994;309:1677-1681.
1995 - Clarke M, Stewart L, Parmar M. Benefits of meta-analyses using individual patient data [abstract]. Proceedings of the Third Cochrane Collaboration Colloquium 1995.
Full publication: Clarke M, Godwin J. Systematic reviews using individual patient data: a map for the minefields? Ann Oncol 1998;9:827-833.
1996 - Liberati A, D'Amico R, Torri V, Tinazzi A, Leonetti C, Pifferi S. Meta-analyses from different sources of information [abstract]. Proceedings of the Fourth Cochrane Colloquium, 1996.
1997 - Berlin J. Does blinding affect the results of meta-analyses? [abstract]. Proceedings of the Fifth Cochrane Colloquium, 1997.
Full publication: Berlin JA, Miles CG, Cirigliano MD, Conill AM, Goldman DR, Horowitz DA, Jones F, Scott E, Hanchak NA, Williams SV. Does blinding of readers affect the results of meta-analyses? Results of a randomised trial. Online J Curr Clin Trials [serial online] 29 May 1997 (Doc No 205).
Full publication: Berlin JA. Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet 1997; 350: 185-186.
1998 - Deeks J, Bradburn M, Bilker
W, Localio R, Berlin J. Much ado about nothing: statistical methods
for meta-analysis with rare events [abstract].
Proceedings of the Sixth Cochrane Colloquium, 1998.
Full publication: Bradburn MJ, Deeks JJ, Berlin JA, Localio RA. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Statistics in Medicine 2007: 26(1): 53-77.
1999 - Higgins J. How should we interpret updated meta-analyses? [abstract]. Proceedings of the Seventh Cochrane Colloquium, 1999.
1999 (second) - Djulbegovic B, Lacevic M, Lyman GH. Empirical verification of the uncertainty principle in conducting randomized trials [abstract]. Proceedings of the Seventh Cochrane Colloquium, 1999.
1999 (third) - Braunholtz D, Lilford R, Chard J. Combining qualitative and
quantitative information in reviews [abstract]. Proceedings of the Seventh Cochrane Colloquium, 1999.
2000 (tie) - Li wan Po A, Herxheimer
A, Poolsup N, Aziiz Z. How do Cochrane reviews address adverse effects
of drug therapy? [abstract].
Proceedings of the Eighth Cochrane Colloquium, 2000.
2000 (tie) - Tierney J, Stewart LA. Investigating patient exclusion
bias in meta-analysis [abstract]. Proceedings of the Eighth Cochrane Colloquium,
2000.
2001 (tie) - Deeks JJ. Half dead
or half alive? Which way should events be coded for meta-analyses
of risk ratios? [abstract].
Proceedings of the Ninth Cochrane Colloquium, 2001.
Full publication: Deeks JJ. Issues in the selection of a summary
statistic for meta-analysis of clinical trials with binary outcomes.
Stat Med 2002;21:1575-1600.
2001 (tie) - Henry D, Moxey A, O'Connell D. Agreement between randomised and non-randomised studies - the effects of bias and confounding [abstract]. Proceedings of the Ninth Cochrane Colloquium, 2001.
2001 (runner-up) - Sterne JAC, Bartlett C, Juni P, and Egger M. Empirical evidence of bias? The hazard of ignoring heterogeneity in meta-epidemiology [abstract]. Proceedings of the Ninth Cochrane Colloquium, 2001.
Full publication: Sterne JAC, Jüni P, Schulz KF, Altman DG, Bartlett C, and Egger M. Statistical methods for assessing the influence of study characteristics on treatment effects in “meta-epidemiological” research. Stat Med 2002;21:1513-1524.
Full publication: Egger M, Jüni P, Bartlett C, Holenstein F. and Sterne JAC. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 2003;7:No.1.
2001 (runner-up) - Olsen O, Gotzsche PC. Quality assessment of mammography screening trials [abstract]. Proceedings of the Ninth Cochrane Colloquium, 2001.
Full publication: Olsen O, Gotzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2001;(4):CD001877. Review.
Full publication: Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-1342.
2002 - Royle P. Obtaining published errata to randomised controlled trials: is it worth the effort? [abstract]. Proceedings of the Tenth Cochrane Colloquium, 2002.
2002 (runner-up) - Napoli M, Schiff H. Survey of American media coverage of the review of mammography trials: an opportunity to educate consumers about the risks of detecting ductal carcinoma in situ [abstract]. Proceedings of the Tenth Cochrane Colloquium, 2002.
2002 (honourable mention) - Telaro E, D’Amico R,
Moja P, Battaglia A, Bianco E, Calderan A,
Colli A, Di Pietrantoni C, Ferri M, Fraquelli M,
Girolami B, Marchioni E, Mezza E, Piccoli G,
Vignatelli L, Liberati A. Quality Assessment in Cochrane
reviews: Do we practice what we preach? [abstract]
Proceedings of the Tenth Cochrane Colloquium, 2002.
2003 Hollis S and Preston C. Allowing for uncertainty due to missing data in a binary meta-analysis.
Better than best/worst case analysis? [presentation]
2004 Marinovich L, Ghersi D, Lord S. Data maturity and systematic reviews of new health technologies [abstract]. Proceedings of the Twelfth Cochrane Colloquium, 2004.
2005 Brok J, Thorlund K, Wetterslev J, Gluud C. Trial sequential analyses of six Cochrane neonatal group meta-analyses considering adequacy of allocation concealment [poster]*. Proceedings of the Thirteenth Cochrane Colloquium, 2005.
and
Salanti G, Higgins J, Marinho V. How to determine the best treatment: a mixed-treatment-comparisons meta-analysis (MTM) of trials of topical fluoride therapies for the prevention of dental caries [presentation]. Proceedings of the Thirteenth Cochrane Colloquium, 2005.
*To enlarge the poster, right-click on the poster image; select 'Zoom' from the pop-up menu, then 'In' from the choices that appear.
2006 Alldred SK. Comparison of two different search strategies in identifying literature for a diagnostic test accuracy review of Down's Syndrome screening [abstract]. Proceedings of the Fourteenth Cochrane Colloquium, 2006.
and
2006 Skipka G. The inclusion of the estimated inter-study variation into forest plots for random-effects meta-analyses - a suggestion for a graphical presentation [poster]. Proceedings of the Fourteenth Cochrane Colloquium, 2006.
2007 Friedrich J, Adhikari N, Ohlsson A, Beyene J. Ratio of means as an alternative to mean differences for analyzing continuous outcome variables in a meta-analysis: a simulation study [abstract]. Proceedings of the Fifteenth Cochrane Colloquium, 2007.
and
2007 Patsopoulos N, Ioannidis J, Evangelou E. Uncertainty of heterogeneity in meta-analysis [poster]. Proceedings of the Fifteenth Cochrane Colloquium, 2007.
2008 (tie) Riley RD, Dodd SR, Craig JV, Williamson PR. Meta-analysis of diagnostic test studies using individual patient data and aggregate data [presentation]. Proceedings of the Sixteenth Cochrane Colloquium, 2008.
and
2008 (tie) Anzures-Cabrera J, Higgins JPT. Expressing meta-analyses of continuous outcomes in terms of risks [abstract]. Proceedings of the Sixteenth Cochrane Colloquium, 2008.
and
2008 Tendal B, Higgins JPT, Jüni P, Hróbjartsson A, Trelle S, Nüesch E, Wandel S, Jørgensen AW, Gesser K, Ilsøe-Kristensen S, Gøtzsche PC. The data extraction challenge: observer variation when extracting data for the calculation of a standardised mean difference [poster]. Proceedings of the Sixteenth Cochrane Colloquium, 2008.
Selection criteria for the Thomas C Chalmers Award
The Thomas C Chalmers Award is given each year to the principal author of the best
oral and poster presentation at the Colloquium. (Note: In 2005, the panel agreed that the Award should in future be given for both the best oral and the best poster presentation.) All accepted posters
and oral presentations will be eligible for the Award if they address
methodological issues related to systematic reviews and demonstrate:
a) originality of thought;
b) high quality science;
c) relevance for the advancement of the science of systematic reviews;
d) clarity of presentation.
Presentations are judged by the Thomas C Chalmers MD Award Committee (see below) and the recipient receives an amount of $1,000 US dollars. If there is a tie, the recipients split the Award. Since 2005, the Award has been administered by the Cochrane Collaboration Secretariat (secretariat@cochrane.org), and the Award has been split equally between the principal author of both the best oral and the best poster presentation.
Award committee for the Thomas C Chalmers Award
2009 - Committee members: To be advised.
The Kenneth Warren Prize
Kenneth Warren, MD
Kenneth Warren was a larger-than-life man who was a source of encouragement
and support for many young people, particularly those living in
developing countries. He was very influential in drawing attention
to the ‘great neglected diseases’ that plague people
in the poorer parts of the world. He was one of the first people
to draw attention to the need for valid summaries of key research
studies and to the way that electronic media could be used to disseminate
the results of health research relevant to people in developing
countries. Ken was an enthusiastic supporter of the pilot work in
pregnancy and childbirth that led to the creation of The Cochrane Collaboration, and, with Fred Mosteller, he co-organised the meeting
at the New York Academy of Sciences at which the vision for The Cochrane Collaboration was first made public [click
here for more information about Ken Warren].
The Kenneth Warren Prize
The Kenneth Warren Prize has been established with individual
and institutional donations to celebrate and recognise Ken’s
interests. It was awarded for the first time at the 8th Cochrane
Colloquium in Cape Town, South Africa, in October 2000. The prize
is awarded annually to the principal author of whichever systematic
review, published electronically on The Cochrane Database of
Systematic Reviews in The Cochrane Library and authored by a national living in a developing
country, is judged to be both of high methodological quality and
relevant to health problems in developing countries. The Prize for any given year is open to the principal author of a review published in Issues 1 or 2 of The Cochrane Library that year, or Issues 3 or 4 of the previous year. The judgement
is made by a panel comprised entirely of nationals of developing
countries [click here for membership of selection
panels]. The Prize recipient receives a certificate and
1000 US dollars. Also, the travel, accommodation and conference registration costs of the Prize recipient and of the Chair of the selection panel are met to enable attendance at the Cochrane Colloquium to receive/present the Prize.
Kenneth Warren Prize recipients
2000 - Marissa Alejandria, University of the Philippines, Manila,
Philippines.
Intravenous immunoglobulin for treating sepsis and septic shock.
[abstract]
and
Anelise Lima, Federal University of Pelotas, Brazil.
Carbamazepine for cocaine dependence. [abstract]
2001 - Manit Srisurapanont, Chiang Mai University, Thailand.
Quetiapine for schizophrenia. [abstract]
2002 - Prathap Tharyan, Christian Medical College, Vellore, India.
Electroconvulsive therapy for schizophrenia. [abstract]
2003 - Maurício Silva de Lima, Federal University of Pelotas, Brazil.
Antidepressants for cocaine dependence. [abstract]
2004 - George Swingler, University of Cape Town, South Africa.
Conjugate vaccines for preventing Haemophilus influenzae type B
infections. [abstract]
2005 - Marilla Lucero, Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. [abstract]
2006 - Jonathan Ipser, MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, South Africa.
Pharmacotherapy for post traumatic stress disorder [abstract].
2007 - Gawrie Galappaththy, Ministry of Health, Colombo, Sri Lanka.
Primaquine for preventing relapses in people with Plasmodium vivax malaria [abstract].
2008 - Martin Meremikwu, University of Calabar, Nigeria. Chemoprophylaxis and intermittent treatment for preventing malaria in children [abstract].
Selection panels for Kenneth Warren
Prize
2000 - Tessa Tan-Torres Edejer (Chair), Karla Soares-Weiser and Patrice Matchaba.
2001 - Karla Soares-Weiser (Chair), Marissa Alejandria, Metin Gülmezoglu and Bongani Mayosi.
2002 - Metin Gülmezoglu (Chair), Marissa Alejandria, Bongani Mayosi and Manit Srisurapanont.
2003 - Bongani Mayosi (Chair), Marissa Alejandria, Manit Srisurapanont and Prathap Tharyan.
2004 - Marissa Alejandria (Chair), Maurício Silva de Lima, Manit Srisurapanont and Prathap Tharyan.
2005 - Manit Srisurapanont (Chair), Prathap Tharyan, Maurício Silva de Lima and George Swingler.
2006 - Prathap Tharyan (Chair), Marilla Lucero, Maurício Silva de Lima and George Swingler.
2007 - Prathap Tharyan (Chair), Jonathan Ipser, Marilla Lucero and George Swingler.
2008 - George Swingler (Chair), Marilla Lucero, Jonathan Ipser and Gawrie Galappaththy.
2009 - Marilla Lucero (Chair), Jonathan Ipser, Gawrie Galappaththy and Martin Meremikwu.
Donors to the Kenneth Warren Prize Fund
Individual donors:
Kenneth Warren’s Family, Cyril Akpom, Jan and Iain Chalmers,
Dr and Mrs Joseph Cook, Murray and Eleanor Enkin, Phyllis Freeman
and Anthony Robbins, Mr and Mrs Alfred Heggie, Adel Mahmoud, Irwin
and Marion Schafer, Chris and Jane Silagy.
Institutional donors:
Current Controlled Trials Ltd; Eugene
Garfield Foundation; Rockefeller
Foundation; The LW Frohlich Charitable Trust.
Additional donations to the Kenneth Warren Prize Fund are very welcome. Anyone wishing to consider making a donation should contact secretariat@cochrane.org.
The Chris Silagy Prize
Chris Silagy, AO, MD
Chris Silagy was the founding Director of the Australasian Cochrane
Centre (1994 to 2001), a former Chair of the Cochrane Collaboration Steering Group, and instrumental in the development
and success of The Cochrane Collaboration. Chris was energetic,
positive and inspiring. Before his death on 13 December 2001,
Chris expressed a wish for a Fund to be established, to be held
by the Monash Foundation. Chris initiated this fund with his own
contribution, and requested donations be made to it instead of flowers
or other tributes after his death.
Chris requested that this Fund be used to recognise contributions to The Cochrane Collaboration in ways that are often insufficiently recognised. For example, providing administration, management, Colloquium organisation, communication and motivation - in short, the 'glue' that helps to keep The Cochrane Collaboration together.
At the Cochrane Collaboration Steering Group meeting in April 2002,
the establishment and perpetuation of this Prize was approved, with
The Cochrane Collaboration agreeing to contribute in kind to the Prize, by
supporting the recipient’s attendance at the Colloquium to receive the Prize.
The Chris Silagy Prize
The Chris Silagy Prize is awarded at every Cochrane Colloquium
to an individual (or team) who has made an extraordinary
contribution to the work of The Cochrane Collaboration. The Prize consists
of 1000 Australian dollars (drawn from the Chris Silagy Memorial
Fund), a certificate which includes the words ‘for an extraordinary
contribution to the work of The Cochrane Collaboration’ (that would not be
recognised outside the scope of this prize) and expenses associated
with attending the Colloquium (to be met by The Cochrane Collaboration).
Scope
- made an extraordinary contribution to The Cochrane Collaboration;
- made a contribution that exceeds the expectations of their employment;
- made a contribution to The Cochrane Collaboration that would not be recognised outside the scope of this Prize (publishing a piece of research work or preparing a Cochrane systematic review do not fall within the scope of this Prize as they qualify for other awards and methods of recognition);
- been identified by their peers as consistently contributing to
a spirit of collaboration.
Chris Silagy Prize recipients
2002 - Jini Hetherington, Cochrane
Collaboration Secretariat
2003 - Gill Gyte, Cochrane Pregnancy and Childbirth
Group
2004 - Sonja Henderson, Cochrane Pregnancy and Childbirth Group
2005 - Janet Wale, Cochrane Consumer Network
2006 - Monica Kjeldstrøm, Nordic Cochrane Centre
2007 - Heather Maxwell, Peripheral Vascular Diseases Group
2008 - Rasmus Moustgaard, Nordic Cochrane Centre
Governing Committee for the Chris Silagy Prize
Jane Russell (Silagy)
Sally Green
David Henderson-Smart
Jini Hetherington (from 2003)
Donations to the Chris Silagy Prize Fund
Donations to this Fund are most welcome.
Cheques should be made payable to 'The Silagy Fund, Monash University' and sent to The Development Office, Building 65, Monash University 3800, 246 Clayton Road, Clayton, Victoria 3168, Australia.
Credit card donations (MasterCard, Bankcard and Visa only) can be faxed to +61 3 9905 2944. The credit card number should be written clearly, and the fax must include the expiry date of the credit card, the name exactly as it appears on the card, and the card holder's full name and address.
Telephone donations can be made to Sara Kelly, The Development Office, Monash University, University Development and Alumni, on +61 3 9905 9957.
Donors to the Chris Silagy Prize Fund
Individual donors:
Professor Leon Piterman; Mrs Pamela R Herman; Professor Elsdon Storey; Ms Lyn Roberts; Dr Wendy Rogers; Professor David Hill; Ms Frances Fairman; Professor Amy E Zelmer; Mr Eric L Garner, AM; Mrs Suzanne Strangward; Dr Rosemary L Nixon; Mrs Joan M McPhee; Mr John L McPhee; Professor Stephen J Duckett; Ms Pauline Pellegrini; Mr NG Taylor; Dr JL Linn; Dr JS Linn; Ms Margaret F Broadhead; Professor Godfrey Fowler; Mrs Jeannett L Hall; Mrs R Allen; Mr Ken R Strangward; Mr Julian F Coles; Ms Janet Coles; Professor MP Vessey.
Institutional donors:
National Heart Foundation of Australia; Mt Waverley District Scout Association.
William (Bill) Silverman (1924-2004) was one of the founders of American neonatal medicine. He was honoured repeatedly as one
of the pioneers in his specialty; however, he often evoked somewhat schizophrenic responses amongst his colleagues because he was in the habit of raising troubling questions about the scientific basis and ethics of his and their practices. Like many of the people who have helped to establish The Cochrane Collaboration, Bill Silverman could be regarded as a ’troublemaker’. As he reiterated frequently, however, criticism is a form of troublemaking that can help to drive progress. Furthermore, criticism should not be limited to examining
the work of others, but should also include self-criticism.
The Bill Silverman Prize acknowledges explicitly the value of criticism of The Cochrane Collaboration, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about health care by providing the best possible evidence on the effects of healthcare interventions. The establishment of the Prize was approved by the Cochrane Collaboration Steering Group in 2007, and awarded for the first time in early 2008.
The Prize is offered annually and the authors of a piece of research published or presented in the preceding twelve months (July 1 to June 30) will be eligible. The criteria for the Prize are that the publication or presentation evaluated any aspect of the preparation, maintenance or dissemination of Cochrane reviews or the work of The Cochrane Collaboration more generally, and:
- was of high quality;
- was accompanied by constructive suggestions on how the relevant aspects of the work of The Cochrane Collaboration could be improved;
- has had, or is likely to have, a positive impact on the scientific quality, relevance and use of Cochrane reviews.
The Prize recipients are announced at the Cochrane Colloquium each year. The prize comprises a cash award of 1000 US dollars and a certificate. (Additional funds are not be available from the Prize fund for the recipients to attend the Cochrane Colloquium.) The cash award goes to the corresponding author of the selected publication or presentation, and it is this person’s responsibility to distribute the award in a fair way to her/his colleagues. The Prize committee will provide details of all nominations that relate to evaluations of any aspect of the preparation, maintenance or dissemination of Cochrane reviews or the work of The Cochrane Collaboration more generally, to The Cochrane Collaboration’s Quality Advisory Group, so that suggestions for improvements can be considered. The committee will also provide details to the Cochrane Methodology Review Group, so that relevant records can be incorporated into the Cochrane Methodology Register.
Nominations
The Prize committee calls for nominations for the Prize in May/June, and issues a reminder a month later. Nominations can be made by anyone, including the authors of the publication or presentation being nominated. Nominations should be e-mailed to the committee co-chairs (see below) with ‘Bill Silverman Prize’ in the subject heading, the citation for the publication or presentation, and a brief explanation of how it meets the criteria for the Prize. The deadline for receipt of nominations is July 31.
Bill Silverman Prize committee
The Prize committee comprises five members, at least three of whom do not have an active role within any Cochrane entity (other than, possibly, as an author or referee of one or more Cochrane reviews). One of these people co-chairs the committee; the other Co-Chair is someone with an active role within a Cochrane entity. Each year, one of the Co-Chairs stands down from the committee, to be replaced as Co-Chair by an existing member. The resulting vacancy on the committee is filled by the recipient of the most recent Prize (or a person chosen by the recipients). The Co-Chairs for 2009 are Cindy Farquhar (internal Co-Chair), Suzanne Hill (external Co-Chair), Ben Goldacre, Jean Slutsky, and Katharina Biester (the 2008 Prize recipient).
Funding for the Prize
Bill Silverman’s family agreed to the establishment of this Prize, and Iain and Jan Chalmers contributed 5000 pounds sterling of start-up funding. These Prize funds are administered by the Cochrane Collaboration Secretariat. The Cochrane Collaboration Steering Group will determine the future of the Prize when this initial contribution has been exhausted and, if relevant, will seek to identify future funding.
Prize recipients
2008 - Biester K et al. High dropout rates in trials included in Cochrane Reviews. Oral presentation at the XIV Cochrane Colloquium, Dublin, Ireland, October 2006 [abstract].
Copyright © The Cochrane Collaboration
Comments for improvement or correction are welcome.
secretariat@cochrane.org
printable